Home › Funds › Sessa Capital IM, L.P. › LXRX
Sessa Capital IM, L.P. position in LXRX
LEXICON PHARMACEUTICALS INC · Health Care
Sessa Capital IM, L.P. reported holding 18,960,836 shares of LXRX (LEXICON PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$45.5M, representing 0.76% of its reported portfolio and ranking #20 among its reported holdings. Sessa Capital IM, L.P. has disclosed LXRX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sessa Capital IM, L.P.'s LXRX position evolved
Sessa Capital IM, L.P. first disclosed a stake in LXRX in Q2 2025 at 3,000,000 shares (US$2.8M). The position peaked in Q2 2026 at 18,960,836 shares, worth US$45.5M. Across 5 filings, Sessa Capital IM, L.P. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 18,960,836 shares valued at US$45.5M — an increase of 1,047,875 shares quarter over quarter.. Notable position changes include a 497% increase in Q1 2026 (shares rose 54% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 3.00M | $2.84M | New |
| Q3 2025 | 3.00M | $4.05M | Hold |
| Q4 2025 | 3.00M | $3.45M | Hold |
| Q1 2026 | 17.91M | $27.94M | Add |
| Q2 2026 | 18.96M | $45.51M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LXRX and 13F data
LXRX (LEXICON PHARMACEUTICALS INC) is a Health Care company. 34 other funds we track also report a position in LXRX — the largest reported positions include Artal Group S.A. (US$420.4M), Siren, L.L.C. (US$106.3M), Ishara Investments LP (US$3.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LXRX
- Artal Group S.A. 175.16M sh · $420.37M · Q2 2026
- Siren, L.L.C. 44.30M sh · $106.33M · Q2 2026
- Ishara Investments LP 1.27M sh · $3.05M · Q2 2026
More on Sessa Capital IM, L.P.
FAQ
How long has Sessa Capital IM, L.P. held LXRX?
Sessa Capital IM, L.P. has disclosed LXRX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is Sessa Capital IM, L.P.'s current position in LXRX?
As of Q2 2026, Sessa Capital IM, L.P. holds 18.96M shares of LXRX (LEXICON PHARMACEUTICALS INC), valued at $45.51M, representing 0.76% of its reported portfolio and ranking #20.
Has Sessa Capital IM, L.P. been buying or selling LXRX?
In the latest 13F filing (Q2 2026), Sessa Capital IM, L.P. increased its position in LXRX. The position peaked in Q2 2026 at 18.96M shares.
Which other funds hold LXRX?
Other major institutional holders of LXRX include Artal Group S.A., Siren, L.L.C., Ishara Investments LP, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.